Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Merck Sharp & Dohme Argentina, Inc. (B) (Spanish version)
Paine, Lynn Sharp; Hogan, Harold F., Jr.Caso HBS-308S09Dirección estratégicaSupplements the (A) case.Desde 5,74 €
-
Merck Sharp & Dohme Argentina, Inc. (A) (Spanish version)
Paine, Lynn Sharp; Hogan, Harold F., Jr.Caso HBS-303S38Dirección estratégicawhether to offer the son of a high-ranking official in the government's national health-care program a place in the company's highly selective intern program for young professionals.Desde 8,20 €
-
Merck Sharp & Dohme Argentina, Inc. (A)
Paine, Lynn Sharp; Hogan, Harold F., Jr.Caso HBS-398033-EConocimiento y comunicaciónDescribes the efforts of the new managing director of Merck's subsidiary for Argentina, Uruguay, and Paraguay to transform the organization and its culture. Focuses on a critical decision: whether to offer the son of a high-ranking official in the governmDesde 8,20 €
-
Taurion Inc. - Built to Cure an Incurable Disease (VCs)
Liechtenstein, Heinrich; Grabenwarter, UliCaso F-874-EFinanzas, Iniciativa emprendedoraTaurion Inc. is a start-up company established in 2006 and based in Vienna. It specializes in researching the causes of Alzheimer's disease (AD) as well as developing diagnostic tools and targeted drugs to combat it. For several years, the founders of the company - two renowned scientists and a finance professional - have been focusing on the role of one deficient protein present in the brains of Alzheimer's patients, the tau protein, which is b...Desde 8,20 €
-
Taurion Inc. - Built to Cure an Incurable Disease (Entrepreneurs)
Ramírez Maz, Daniel; Liechtenstein, Heinrich; Grabenwarter, UliCaso F-873-EFinanzas, Iniciativa emprendedora, Innovación y cambioTaurion Inc. is a start-up company established in 2006 and based in Vienna. It specializes in researching the causes of Alzheimer's disease (AD) as well as developing diagnostic tools and targeted drugs to combat it. For several years, the founders of the company - two renowned scientists and a finance professional - have been focusing on the role of one deficient protein present in the brains of Alzheimer's patients, the tau protein, which is be...Desde 8,20 €